Metabolic Heterogeneity in Cervical Cancer and Disease Outcome
Author Information
Author(s): Frank J Brooks, Perry W Grigsby
Primary Institution: Washington University School of Medicine
Hypothesis
Do current measures of metabolic heterogeneity within cervical cancer predict disease outcome?
Conclusion
Current measures of intra-tumoral metabolic activity are not predictive of disease outcome.
Supporting Evidence
- The previously published measure of intra-tumoral heterogeneity is a surrogate for tumor volume.
- An optimized linear combination of non-spatial metabolic quantifiers does not predict disease outcome.
- Patients categorized by metabolic heterogeneity do not show distinct survival outcomes.
Takeaway
The way we measure differences in cancer cells' energy use doesn't actually help us predict how well treatment will work.
Methodology
Re-analysis of FDG-PET imagery data and principal component analysis of metabolic quantifiers.
Potential Biases
Potential bias due to the grouping of patients with persistent disease and new metastases.
Limitations
The study relies on previously published data and may not account for all variables affecting disease outcome.
Participant Demographics
Patients with cervical cancer who underwent FDG-PET scans.
Statistical Information
P-Value
p = 0.36 for successful treatment, p = 0.24 for unsuccessful treatment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website